TÀI LIỆU THAM KHẢO
TÀI LIỆU TIẾNG VIỆT
1. Bộ Y Tế (2012), thông tư 31/2012/TT – BYT: “Hướng dẫn hoạt động dược lâm sàng trong bệnh viện”. pp. 9-12.
2. Bộ Y Tế (2002), Dược thư quốc gia Việt Nam, Nhà xuất bản Y học, pp. 785-788.
3. Glaxosmithkline, Thông tin sản phẩm AUGMENTIN ® tablets, Số đăng ký VN-5377-10.
4. Hoàng Thị Kim Huyền (2006), Dược lâm sàng, Nhà xuất bản Y học, Hà Nội, pp. 9-12.
5. Italia Srl Pfizer, Thông tin sản phẩm MEDROL®, số đăng ký VN-13806- 11.
6. Pharma Polfatarchomin, Thông tin sản phẩm Tarcefandole, Số đăng ký VN-17603-13.
7. Lê Ngọc Trọng (2006), Hướng dẫn điều trị NXB Y học, pp. 67.
Có thể bạn quan tâm!
-
Xây Dựng Hướng Dẫn Điều Trị Thống Nhất Áp Dụng Toàn Khoa -
Phương Pháp Phát Hiện Vấn Đề Liên Quan Đến Sử Dụng Thuốc -
Xác định các vấn đề liên quan đến sử dụng thuốc thông qua hoạt động thực hành dược lâm sàng tại khoa Mũi xoang Bệnh viện Tai Mũi Họng Trung ương - 9
Xem toàn bộ 86 trang tài liệu này.
TÀI LIỆU TIẾNG ANH
8. Ahabet M.H., Rogers J.H., (1989), "Methylprednisolone pharmacokinetics after intravenous and oral administration", Br. J. clin. Pharmac, 27, pp. 285-290.
9. American Academy of Pediatrics (2003), "Group A Streptococcal Infection", Am Acad Pediatr, pp. 573-84.
10. Anthony W.C., et al., (2012), "IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults", oxfordjournal, pp. 1-41.
11. April M. M., et al., (1996), "The effect of intravenous dexamethasone in pediatric adenotonsillectomy", Arch Otolaryngol Head Neck Surg, 122(2), pp. 117-20.
12. Aronson J.K., (2006), MEYLER’S side effects of drugs – The international encyclopedia of adverse drug reactions and interactions, pp. 930.
13. Assanasen P., Robert M.N., (2001), "Medical and surgical management of nasal polyps - Current Opinion in Otolaryngology and Head and Neck Surgery", Lippincott Williams & Wilkins, 9, pp. 27-36.
14. Baker J., (1988), "Seventeen years experience of a voluntary based drug rationalisation programme in hospital", Br Med J, 297, pp. 465-469.
15. Bond C. A., Raehl C. L., (2007), "Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients", Am J Health Syst Pharm, 64(18), pp. 1935-42.
16. Brennan N., Mattick K., (2013), "A systematic review of educational interventions to change behaviour of prescribers in hospital settings, with a particular emphasis on new prescribers", Br J Clin Pharmacol, 75(2), pp. 359-72.
17. Bricks L.F., (2003), "Judicious use of medication in children", J Red, 1, pp. S107-14.
18. Byron J. B., (1998), "Head and Neck Surgery Otolaryngolory", 2, pp. 731- 735.
19. Calder G., Barnett J.W., (1967), "The pharmacist in the ward", Pharm J, 198, pp. 584-586.
20. Calvert R.T., (1999), "Clinical pharmacy—a hospital perspective", Br J Clin Pharmacol, 47(3), pp. 231-238.
21. Chaillet N., et al., (2006), "Evidence-based strategies for implementing guidelines in obstetrics: a systematic review l", Obstet Gyneco, 108(5), pp. 1234-45.
22. Charles W.C., (2005), "Otolaryngolory Head and Neck Surgery", 4, pp. 2227-2228.
23. Col N., Fanale J.E., Kronholm P., (1990), "The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly", Arch Intern Med, 150(4), pp. 841-5.
24. Cummingham G. D., Grant D.J., (1997), "Drug related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment", Age Aging, 26, pp. 375-82.
25. David M. P., et al., (2013), "Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence- based review with recommendations", International Forum of Allery & Rhinology, 3(2), pp. 458-69.
26. Dhiwakar M., et al., (2010), "Antibiotics to reduce post-tonsillectomy morbidity", Cochrane Database Syst Rev, (7), pp. Cd005607.
27. Dhiwakar M., et al., (2006), "Antibiotics to improve recovery following tonsillectomy: a systematic review", Otolaryngol Head Neck Surg, 134(3), pp. 357-64.
28. Eli O.M., Daniel L.H., (2011), "Rhinosinusitis diagnosis and management for the clinician: A synopsis of recent consensus guideline", Mayo Clin Proc, 86(5), pp. 427-443.
29. Elizabeth M.E., et al., (2014), "Interventions to reduce medication errors in pediatric intensive care", Annals of Pharmacotherapy, pp. 1-19.
30. Escmid Sore Throat Guideline Group (2012), "Guideline for the management of acute sore throat", 18, pp. 3-19.
31. Finley P.R., et al., "Impact of a collaborative pharmacy practice model on the treament of depression in primary care", Am J Health Syst Pharm, 59, pp. 1518-26.
32. Frush K., et al., (2006), "Evaluation of a Web-based education program on reducing medication dosing error: a multicenter, randomized controlled trial", Pediatr Emerg Care, 22(1), pp. 62-70.
33. Gerald K.M., et al., (2014), Methylprednisolon, in AHFS drug information, Editors, American Society of Health-System Pharmacist, pp.
34. Gillespie U., (2012), "Effects of clinical pharmacist’s intervention on Drug Related Hospitalisation and Appropriateness of Prescribing in Elderly Patients", Digital Comprehensive summaries of uppsalo dissertations from the faculty of pharmacy, 154, pp. 345-65.
35. Grindrod K. A., Patel P., Martin J. E., (2006), "What interventions should pharmacists employ to impact health practitioners' prescribing practices?", Ann Pharmacother, 40(9), pp. 1546-57.
36. Hakkenness S., Dodd K., (2008), "Guideline implementation in allied health professions: a systematic review of the literature", Qual Saf Health Care, 17(4), pp. 296-300.
37. Hallas J., et al. (1992), "Drug related admissions to medical wards: a population based survey", Br J Clin Pharmacol, 33(1), pp. 61-8.
38. Hatfield M.D., et al., (2014), "Impact of computerlized order entry on pharmacist productivity", Hosp Pharm, 49(5), pp. 458-65.
39. Haumschild M.J., et al., (2003), "Clinical and ecomomic outcomes of a fall-focused pharmaceutical intervention program", Am J Health Syst Pharm, 60, pp. 1029-32.
40. Jonathan R.N., Ah-See K.W., (2008), "A review of nasal polyposis",
Therapeutics and Clinical Risk Management, 4(2), pp. 507-512.
41. Knapp D., (1979), "Strategy for increasing the demand for clinical pharmacist", Am j Hosp Pharm 36(11), pp. 1553-4.
42. Kopp B.J., et al., (2007), "Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist", Am J Health Syst Pharm, 64, pp. 2483-7.
43. Lee J. K., et al., (2013), "Geriatric patient care by U.S. pharmacists in healthcare teams: systematic review and meta-analyses", J Am Geriatr Soc, 61(7), pp. 1119-27.
44. Manias E., Williams A., Liew D., (2012), "Intervention to reduce medication errors in adult intensive care: a systematic review", British Journal of Clinical Pharmacology, 74(3), pp. 411-423.
45. Mannesse C., Derkx F.H, De Ridder M.A., (2000), "Contribution of adverse drug reactions to hospital admissions of older patients", Age Aging, 29, pp. 35-9.
46. Marek L.K., (2011), "Oral and Nasal Steroids for Nasal Polyps", Curr Allergy Asthma Rep, 11, pp. 187-188.
47. Martin D., et al., (2011), "Candian clinical practice guidelines for acute and chronic rhinosinusitis", Journal of otolaryngology – head neck surgery, 40, pp. S2.
48. Martinez D.P., Patiar S., (2011), "Oral steroids for nasal polyps (Review)", the Cochrane Library 2011, (7), pp. 1456-78.
49. Marvin W.S., (1960), "Intranasal injection of corticosteroids", Clifornia medicine, 92(2), pp.
50. Metlay J. P., et al., (2007), "Cluster-randomized trial to improve antibiotic use for adults with acute respiratory infections treated in emergency departments", Ann Emerg Med, 50(3), pp. 221-30.
51. Mil F.V., (2005), "Drug related problems: a cornerstone for pharmaceutical care ", Journal of the Malta College of Pharmacy Practise, (10), pp. 123-45.
52. Miller R. R., (1981), "History of clinical pharmacy and clinical pharmacology", J Clin Pharmacol, 21(4), pp. 195-7.
53. Ministry of Health Malaysia (2011), "Malaysian Guideline for Good Clinical Practice", Third Edition, pp. 1-85.
54. Ministry of Health Malaysia (2003), "management of sowrre throat", pp. 7-10.
55. Mocoy A.B., et al., (2014), "Clinical decision support alert appropriateness a review and proposal for improvement", Ochsner J, 14(2), pp. 195-202.
56. Neuspiel D.R., Tayler M.M., (2013), "Reducing the risk of harm from medication errors in children", 6, pp. 47-59.
57. Oddone E.Z., et al., (1996), "Classifying general medicine readmissions. Are they preventable? ", J Gen Intern Med, 11(10), pp. 597-607.
58. Otolaryngology Head and Neck Surgery (2011), "Clinical practice guideline: Tonsillectomy in Children", Americian Academy of Otolaryngology, 144(IS), pp. S1-S30.
59. Otolaryngology Head and Neck Surgery (2007), "Clinical practice guideline: Aldult sinusitis", pp. S1-S31.
60. Paul W.F., et al., (2010), Cummings Otolaryngology Head and Neck Surgery fifth edition, pp. 739-59.
61. Paulino E. I., et al., (2004), "Drug related problems identified by European community pharmacists in patients discharged from hospital", Pharm World Sci, 26(6), pp. 353-60.
62. Pedersen C. A., Schneider P. J., Scheckelhoff D. J., (2014), "ASHP national survey of pharmacy practice in hospital settings: Prescribing and transcribing-2013", Am J Health Syst Pharm, 71(11), pp. 924-42.
63. Perez A., et al., (2009), "ACCP: economic evaluations of clinical pharmacy services: 2001-2005", Pharmacotherapy, 29(1), pp. 128.
64. Pharmaceutical Care Network Europe Foundation (2006), "PCNE classification for drug related problems V 5.01", pp. 1-9.
65. Pharmaceutical Society of Australia (2011), "Standard and guidelines for pharmacists performing clinical interventions", J Pharm Pract Res, 35(2), pp. 122-46.
66. Raehl C.L, Bond C.A, Pitterle M.E., (1990), "Hospital pharmacy services in the Great Lakes region", Am J Hosp Pharm, 49, pp. 1283–303.
67. Raehl C.L., Bond C.A., (1998), "National clinical pharmacy services study", Pharmacotherapy 2000, 20, pp. 436-60.
68. Raehl C.L., Bond C.A., Pitterle M.E., (1995), "National clinical pharmacy services survey", Pharmacotherapy 1998, 18, pp. 302-26.
69. Raehl C.L., Bond C.A., Pitterle M.E., (1992), "National clinical pharmacy services survey", Pharmacotherapy 1994, 14, pp. 282-304.
70. Raehl C.L., Bond C.A., Pitterle M.E., (1992), "Pharmaceutical services in
U.S. hospitals in 1989", Am J Hosp Pharm 49, pp. 323-46.
71. Randy M.L., William W.W., Robert C.K., et al., (2013), Bailey's Head and Neck Surgery - otolayrngology fifth edition, pp. 237-67.
72. Ranji S.R., Rennke S., Wachter R.M., (2014), "Computerlized provider order entry combined with clinical decision support system to improve medication safety: a narrative review ", BMJ Qual Saf, 23(9), pp. 733-780.
73. Roxanne S.L., et al., (2008), "The diagnosis and management of acute and chronic sinusitis", Prim care clin office pract, 35, pp. 11-24.
74. Scandding G.K., et al., (2007), "BSACI guidelines for management of rhinosinusitis and nasal polyposis ", Clinical and Experimental Allergy, 38, pp. 260-275.
75. Schumock G.T., et al., (1996), "Economic evaluations of clinical pharmacy services: 1988-1995", Pharmacotherapy, 16, pp. 1188-208.
76. Scottish Intercollegiate Guidelines Network (2010), "Management of sore throat and indications for tonsillectomy 117", pp. 3-5.
77. Spinks A., Glasziou P. P., Del M.C., (2009), "Antibiotics for sore throat (Review)", The Cochrane Library 2009, (4), pp. 2-35.
78. Splinter W. M., Roberts D. J., (1996), "Dexamethasone decreases vomiting by children after tonsillectomy", Anesth Analg, 83(5), pp. 913-6.
79. Sweetman C.S., (2009), “Martindale – The complete drug reference”, Thirty-sixth edition, pp. 1492.
80. Tania M.S., Lucia F.B., (2008), "Optimizing the Management of the main acute infections in pediatric ORL: Tonsillitis, Sinusitis, Otitis media", Rew Bras Otorrinolaringol, 74(5), pp. 755-62.
81. Tatsuno M., (1994), "History of professionalization of modern clinical pharmacist - The birth of clinical medicine and clinical pharmacy", Yakushigaku Zasshi, 29(3), pp. 489-97.
82. The National Asociation of Pharmacy Regulatory Authorities, Model Standard of Practice of Canadian Pharmacist. 2009. p. 1-22.
83. The Society of Hospital Pharmacist of Australia (2005), "SHPA Standards of Practise for Clinical Pharmacy", J Pharm Pract Res, 35(2), pp. 122-46.
84. Thomas D.R., Ludo W., Steven S., (2008), "Economic effects of clinical pharmacy interventions: A literature rewiew", Am J Health Syst Pharm, 65, pp. 1161-1172.
85. Vinson J.M., et al., (1990), "Early readmission of elderly patients with congestive heart failure", J Am Geriatr Soc, 38(12), pp. 1290-5.
86. Vò T.H., et al., (2013), "Pharmacy Education in Vietnam", Am J Pharm Educ, 77(6), pp. 114.
87. Willett M. S., et al., (1989), "Prospectus on the economic value of clinical pharmacy services: a position statement of the American College of Clinical Pharmacy", Pharmacotherapy, 9, pp. 45-56.
88. Williams H.L., Shure N., (1952), "Use of cortisone and corticotropin in the field of otorhinology and laryngology", Ann Otol 61, pp. 497-504.
89. Zenziper Y., et al., (2014), "Implementation of a clinical decision support system for computerized drug prescription entries in a large tertiory care hospital", Isr Med Assoc J, 16(5), pp. 289-94.
WEBSITE
90. American College of Clinical Pharmacy (2014, 29/8/2014), "About clinical pharmacist", Retrieved, from http://www.accp.com/about/clinicalpharmacists.aspx.
91. European Society of Clinical Pharmacy (2014, 11/9/2014), "What is clinical pharmacy?", Retrieved, from http://www.escpweb.org/cms/Clinical_pharmacy.
92. Ankit P., Arlen D.M., et al., (2012, 10/10/2014), "Funtional Endoscopic Sinus Surgery", Retrieved, from http://emedicine.medscape.com/article/863420-overview#showall.